Francine Behar-Cohen
Oprichter bij Eyevensys SAS
Profiel
Francine Behar-Cohen is the founder.
She founded Kiora Pharmaceuticals, Inc. in 1998, EarlySight SA in 2019, and Eyevensys SAS in 2008.
At Eyevensys SAS, she holds the title of Director & Chief Innovation Officer.
Actieve functies van Francine Behar-Cohen
| Bedrijven | Functie | Begin |
|---|---|---|
Eyevensys SAS
 Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Oprichter | 08-12-2008 |
Eerdere bekende functies van Francine Behar-Cohen
| Bedrijven | Functie | Einde |
|---|---|---|
EarlySight SA
 EarlySight SA Medical SpecialtiesHealth Technology EarlySight SA engages in the development, production, and marketing of imaging solutions for the medical and life science sectors. It focuses primarily on the development of an eye camera for the monitoring of the tissue degenerative process associated with retinal diseases. The company was founded by Timothé Laforest, Mathieu Kunzi, Christophe Moser, and Francine Behar-Cohen in 2019 and is headquartered in Lausanne, Switzerland. | Oprichter | - |
| KIORA PHARMACEUTICALS, INC. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Commercial Services |
EarlySight SA
EarlySight SA Medical SpecialtiesHealth Technology EarlySight SA engages in the development, production, and marketing of imaging solutions for the medical and life science sectors. It focuses primarily on the development of an eye camera for the monitoring of the tissue degenerative process associated with retinal diseases. The company was founded by Timothé Laforest, Mathieu Kunzi, Christophe Moser, and Francine Behar-Cohen in 2019 and is headquartered in Lausanne, Switzerland. | Health Technology |
